Search Browse Earnings

SOLENO THERAPEUTICS INC — SlamSEC

SOLENO THERAPEUTICS INC

Nasdaq:SLNO

Pharmaceutical Preparations·REDWOOD CITY, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$607,472

FY 2016

Adj. EBITDA

-$39.4M

-6490.2% margin

FY 2025

Net Income

-$39.0M

-6418.1% margin

FY 2025

EPS (Diluted)

-$2.36

FY 2025

Stock Price

$40.62

+2.2%

2026-03-10

52W Range

$32.63 – $90.32

P/E Ratio

-17.2x

Market Cap

$2.1B

Cash

$87.9M

FY 2025

Total Debt

$49.8M

FY 2025

Net Cash

$38.1M

FY 2025

Enterprise Value

$2.1B

Debt / EBITDA

1.0x

FY 2016

EV / EBITDA

-52.2x

Employees

—